Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function (Q44510445)

3 December 2017

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function (English)

1 reference

3 December 2017

1 reference

1 reference

Astrid Spruss

1

1 reference

3 December 2017

Giridhar Kanuri

2

1 reference

3 December 2017

Carolin Stahl

3

1 reference

3 December 2017

Stephan C Bischoff

4

1 reference

3 December 2017

Ina Bergheim

5

1 reference

3 December 2017

23 April 2012

1 reference

3 December 2017

Laboratory Investigation

1 reference

3 December 2017

92

1 reference

3 December 2017

1020-1032

1 reference

3 December 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2012.75

3 December 2017

0 references

cites work

Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Consuming fructose-sweetened beverages increases body adiposity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Metformin prevents endotoxin-induced liver injury after partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Metformin Causes a Reduction in Basal and Post-venous Occlusion Plasminogen Activator Inhibitor-1 in Type 2 Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Effect of obesity on growth-related oncogene factor-alpha, thrombopoietin, and tissue inhibitor metalloproteinase-1 serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.75

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2012.75

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference